%0 Journal Article %J Mol Immunol %D 2016 %T CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response. %A Zupin, Luisa %A Polesello, Vania %A Alberi, Giulia %A Moratelli, Giulia %A Crocè, Saveria Lory %A Masutti, Flora %A Pozzato, Gabriele %A Crovella, Sergio %A Segat, Ludovica %X

Hepatitis C is a severe liver disease caused by hepatitis C virus that could persist in the host causing progression towards chronic disease in about 80% of the cases. Pegylated-interferon plus ribavirin was the gold standard therapy, however treatment's response was quite variable among individuals and different host/viral factors may play a role in disease outcome. The cluster of differentiation 209 (CD209 antigen) is a component of the innate immune system able to recognize HCV and consequently activating the immune response. We enrolled 203 Italian HCV infected patients and 220 healthy controls investigating if five promoter polymorphisms within CD209 gene (encoding for CD209 antigen) correlated with HCV infection susceptibility, spontaneous viral clearance and interferon treatment response. CD209 -939G>A and -871A>G polymorphisms associated with HCV infection susceptibility, while, CD209 -871A>G and -336A>G polymorphisms associated with response to treatment. In conclusion, CD209 polymorphisms could play a role in the susceptibility to HCV infection as well as interferon treatment response in our study population from North-East of Italy.

%B Mol Immunol %V 76 %P 49-54 %8 2016 Aug %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27348632?dopt=Abstract %R 10.1016/j.molimm.2016.06.009 %0 Journal Article %J Arch Oral Biol %D 2015 %T Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration. %A Polesello, Vania %A Zupin, Luisa %A Di Lenarda, Roberto %A Biasotto, Matteo %A Ottaviani, Giulia %A Gobbo, Margherita %A Cecco, Luca %A Alberi, Giulia %A Pozzato, Gabriele %A Crovella, Sergio %A Segat, Ludovica %X

OBJECTIVES: Human β-defensin 1 (hBD-1) is an antimicrobial peptide involved in epithelial defence of various tissues, also present in the saliva. Individual genetic variations within the DEFB1 gene, encoding for hBD-1, could influence gene expression and protein production.

DESIGN: Three DEFB1 polymorphisms at 5' untranslated region (UTR), -52G > A (rs1799946), -44C > G (rs1800972) and -20G > A (rs11362), and two polymorphisms at DEFB1 3' UTR, c*5G > A (rs1047031) and c*87A > G (rs1800971), were analysed by direct sequencing and correlated with hDB-1 salivary concentration (tested with enzyme-linked immunosorbent assay (ELISA)) in 40 healthy subjects.

RESULTS: Significant associations were found between individuals presenting different DEFB1 polymorphisms at positions -52 and -44 of the gene and hBD-1 salivary concentrations: -52 G/G carriers had higher levels of protein than G/A and A/A; -44C/G subjects showed a higher protein concentration than homozygous wild-type C/C. For the -20G > A, c*5G > A and c*87A > G polymorphisms, no statistically significant differences were found. Combined haplotype analysis confirmed the results obtained considering the single-nucleotide polymorphisms (SNPs) singularly.

CONCLUSION: Polymorphisms in the DEFB1 gene influence hBD-1 production and, therefore, could modify the innate immune system responses and, consequently, the oral health.

%B Arch Oral Biol %V 60 %P 1054-8 %8 2015 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25939140?dopt=Abstract %R 10.1016/j.archoralbio.2015.03.009